Catherine Ivy's guest appearances

Catherine Ivy

The Onco'Zine Brief

Charlie Johnson

Noopur Raje

Otis Brawley

Armon Sharei

Neil Canavan

Richard Schilsky

Susan Rafte

Anna Sureda

Manon Rinsma

Phil Rowlands

Valena Wright

OwlTail

In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben &amp; Catherine Ivy Foundation. The Ben &amp; Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma (GBM) - research in the world. To date, the Ivy Foundation has funded clinical trials and basic science in North America, Europe, and Asia.  Glioblastoma, also known as glioblastoma multiforme, is an aggressive type of cancer that can occur in the brain or spinal cord. Glioblastoma forms from cells called astrocytes, that support nerve cells. The disease can occur at any age, but tends to occur more often in older adults. Glioblastoma can cause worsening headaches, nausea, vomiting and seizures. It can be very difficult to treat and a cure is often not possible. Catherine Ivy, is a tireless advocate for glioblastoma patients everywhere.  Since 2005, the Ivy foundation has committed more than US $ 92 million to brain tumor research.  The expectation is that this investment will, in time, lead to an eventual cure. The Ivy Foundation is dedicated to this effort because funding leads to answers, and answers lead to hope.Ivy Foundation-supported research is always patient-focused and highly translational.  The organizational philosophy is to embrace risk, advocate collaboration, and fiercely support the brain tumor patient community.  This forward-leaning strategy reflects the ideals of both Ms. Ivy and her late husband, Ben, who died from a glioblastoma in 2005.  In this interview with The Onco'Zine Brief, Catherine Ivy tells the story of her husband, Ben Ivy, who was diagnosed with glioblastoma in August 2005. In addition to his devastating diagnosis, Ben’s suffering made a difficult situation overwhelmingly painful –  Ben Ivy passed away four months after being diagnosed, in November 2005. Ben and Catherine Ivy felt it was important to give back to their community and they’ve always actively supported education and healthcare. Following Ben’s death, the Ben and Catherine Ivy foundation refocused its mission to find a cure for brain cancer.  Catharine Ivy explained that her husband’s suffering and the awareness of the lack of options to fight brain cancer motivated her to find better diagnostics and to develop new therapies to help patients.And that’s what she did.The mission of the Ben and Catherine Ivy Foundation is to fund brain cancer research in order to develop diagnostics and treatments that lead to long-term survival and a high quality of life for patients with this disease. More information about the Ben and Catherine Ivy FoundationFor more information about the Ben and Catherine Ivy Foundation, visit the website of the organization at:  www.ivyfoundation.org About Onco'ZineThe Onco’Zine Brief is developed in collaboration with the online journal, Onco’Zine at oncozine.com - where you can find additional information and the latest news about cancer, cancer diagnosis and treatment, and cancer prevention.How to support The Onco'Zine BriefFor more information about supporting The Onco’Zine Brief, check our online journal Onco’Zine at Onco’Zine.com or visit Patreaon at https://www.patreon.com/theoncozinebriefNewsletterIf you’re living in the United States and want to receive our Newsletter, text the word CANCER to 66866 - and we’ll make sure that you’ll receive our newsletter which includes an overview of the latest news in oncology and hematology.Read more- Hofland P. First-in-human Study to Determine Effectiveness of Novel, Non-invasive Therapy for Brain Cancer. Onco'Zine. November 21, 2019. Online: https://www.oncozine.com/first-in-human-study-to-determine-effectiveness-of-novel-non-invasive-therapy-for-brain-cancer/- Hofland P. New Breast Cancer Drug has the Potential to be a Novel Therapy for Glioblastoma. Onco'Zine, July 25, 2019. Online: https://www.oncozine.com/new-breast-cancer-drug-has-the-potential-to-be-a-novel-therapy-for-glioblastoma/- Nader Sanai, MD, FAANS, FACS. As New Drugs Lag, Accelerated Clinical Trials Lead Charge in Brain Cancer Fight? Onco'Zine. April 12, 2019. Online: https://www.oncozine.com/as-new-drugs-lag-accelerated-clinical-trials-lead-charge-in-brain-cancer-fight%ef%bb%bf/

In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben &amp; Catherine Ivy Foundation. The Ben &amp; Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma (GBM) - research in the world. To date, the Ivy Foundation has funded clinical trials and basic science in North America, Europe, and Asia.  Glioblastoma, also known as glioblastoma multiforme, is an aggressive type of cancer that can occur in the brain or spinal cord. Glioblastoma forms from cells called astrocytes, that support nerve cells. The disease can occur at any age, but tends to occur more often in older adults. Glioblastoma can cause worsening headaches, nausea, vomiting and seizures. It can be very difficult to treat and a cure is often not possible. Catherine Ivy, is a tireless advocate for glioblastoma patients everywhere.  Since 2005, the Ivy foundation has committed more than US $ 92 million to brain tumor research. The expectation is that this investment will, in time, lead to an eventual cure. The Ivy Foundation is dedicated to this effort because funding leads to answers, and answers lead to hope. Ivy Foundation-supported research is always patient-focused and highly translational.  The organizational philosophy is to embrace risk, advocate collaboration, and fiercely support the brain tumor patient community.  This forward-leaning strategy reflects the ideals of both Ms. Ivy and her late husband, Ben, who died from a glioblastoma in 2005.  In this interview with The Onco'Zine Brief, Catherine Ivy tells the story of her husband, Ben Ivy, who was diagnosed with glioblastoma in August 2005. In addition to his devastating diagnosis, Ben’s suffering made a difficult situation overwhelmingly painful – Ben Ivy passed away four months after being diagnosed, in November 2005.  Ben and Catherine Ivy felt it was important to give back to their community and they’ve always actively supported education and healthcare. Following Ben’s death, the Ben and Catherine Ivy foundation refocused its mission to find a cure for brain cancer.  Catharine Ivy explained that her husband’s suffering and the awareness of the lack of options to fight brain cancer motivated her to find better diagnostics and to develop new therapies to help patients. And that’s what she did. The mission of the Ben and Catherine Ivy Foundation is to fund brain cancer research in order to develop diagnostics and treatments that lead to long-term survival and a high quality of life for patients with this disease. More information about the Ben and Catherine Ivy Foundation For more information about the Ben and Catherine Ivy Foundation, visit the website of the organization at: <a href="http://www.ivyfoundation.org" rel="noopener nofollow" target="_blank">www.ivyfoundation.org</a> About Onco'Zine The Onco’Zine Brief is developed in collaboration with the online journal, Onco’Zine at <a href="http://oncozine.com" rel="nofollow" target="_blank">oncozine.com</a> - where you can find additional information and the latest news about cancer, cancer diagnosis and treatment, and cancer prevention. How to support The Onco'Zine Brief For more information about supporting The Onco’Zine Brief, check our online journal Onco’Zine at Onco’<a href="http://Zine.com" rel="nofollow" target="_blank">Zine.com</a> or visit Patreaon at <a href="https://www.patreon.com/theoncozinebrief" rel="noopener nofollow" target="_blank">https://www.patreon.com/theoncozinebrief</a> Newsletter If you’re living in the United States and want to receive our Newsletter, text the word CANCER to 66866 - and we’ll make sure that you’ll receive our newsletter which includes an overview of the latest news in oncology and hematology. Read more - Hofland P. First-in-human Study to Determine Effectiveness of Novel, Non-invasive Therapy for Brain Cancer. Onco'Zine. November 21, 2019. Online: <a href="https://www.oncozine.com/first-in-human-study-to-determine-effectiveness-of-novel-non-invasive-therapy-for-brain-cancer/" rel="noopener nofollow" target="_blank">https://www.oncozine.com/first-in-human-study-to-determine-effectiveness-of-novel-non-invasive-therapy-for-brain-cancer/</a> - Hofland P. New Breast Cancer Drug has the Potential to be a Novel Therapy for Glioblastoma. Onco'Zine, July 25, 2019. Online: <a href="https://www.oncozine.com/new-breast-cancer-drug-has-the-potential-to-be-a-novel-therapy-for-glioblastoma/" rel="noopener nofollow" target="_blank">https://www.oncozine.com/new-breast-cancer-drug-has-the-potential-to-be-a-novel-therapy-for-glioblastoma/</a> - Nader Sanai, MD, FAANS, FACS. As New Drugs Lag, Accelerated Clinical Trials Lead Charge in Brain Cancer Fight? Onco'Zine. April 12, 2019. Online: <a href="https://www.oncozine.com/as-new-drugs-lag-accelerated-clinical-trials-lead-charge-in-brain-cancer-fight%ef%bb%bf/" rel="noopener nofollow" target="_blank">https://www.oncozine.com/as-new-drugs-lag-accelerated-clinical-trials-lead-charge-in-brain-cancer-fight%ef%bb%bf/</a>

Catherine Ivy: A Tireless Advocate for Brain Cancer Patients